Home › NDC Lookup › Ingredients › Lansoprazole › 45802-0878-03
lansoprazole 15 mg Capsule, Delayed Release — NDC 45802-0878-03 package photo

lansoprazole 15 mg Capsule, Delayed Release

by Padagis Israel Pharmaceuticals Ltd · 3 BOTTLE in 1 CARTON (45802-878-03) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
NDC 45802-0878-03
🏷️ FDA NDC (as labeled) 45802-878-03 billing pads the product segment with a zero
This package
Contains14 capsule, delayed release in 1 bottle Cost per ea$0.4067 NADAC Per package$17.08 / 42 capsules Pack sizes3 compare ↓
Also priced by: Part D plans $0.4438/unit — full pricing hub ↓
Also comes in: 14 capsules 45802-0878-01 14 capsules 45802-0878-02
OTC Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 45802-878-03
Product NDC 45802-878
11-digit billing NDC 45802087803
NCPDP billing unit EA — each (per item)
RxCUI 596843
UNII 0K5C5T2QPG
Application # ANDA202319
SPL Set ID 17f41872-f3d1-4b02-b6ce-0e731139495a
Established class (EPC) Proton Pump Inhibitor
Mechanism of action Proton Pump Inhibitors
Physiologic effect Inhibition Gastric Acid Secretion
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-07-29
Route ORAL
Dosage form CAPSULE, DELAYED RELEASE
Substance LANSOPRAZOLE
GPI-14 49270040006510
GCN Seq No 030106
GCN 01697
HICL code 008993
Ingredient (HICL) Lansoprazole
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4J
Therapeutic class — specific (HIC3) Proton-Pump Inhibitors
AHFS code 56:28.36.00
AHFS class Proton-Pump Inhibitors
FDB label name LANSOPRAZOLE DR 15 MG CAPSULE
FDB brand name Lansoprazole
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 45802-878-03 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 45802-0878-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Proton Pump Inhibitor class.

Pharmacologic class Proton Pump Inhibitor
Drug family (ATC) Proton pump inhibitors
How it works Proton Pump Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerPadagis Israel Pharmaceuticals Ltd
Application holderPERRIGO R AND D CO
FDA applicationANDA202319 (ANDA)
Labeler code45802
First marketedJul 2021
Product typeHuman Otc Drug
Portfolio175 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name LANSOPRAZOLE DR 15 MG CAPSULE Ingredient Lansoprazole
📗 Our plain-language guide HelloPharmacist
  • It does a lot more than heartburn relief. Lansoprazole is used to heal ulcers in the stomach and small intestine, treat acid reflux disease (GERD), repair acid damage to the esopha...
  • What exactly is lansoprazole treating — is it just for heartburn?
  • Timing actually matters quite a bit with lansoprazole. It works best when taken before a meal — ideally about 30 minutes before you eat. If you take it after food, your body absorb...
  • Does it matter when I take it — can I just take it whenever it's convenient?
📖 Read our full Lansoprazole guide →
9
Nutrient depletion considerations

Lansoprazole may be associated with lower levels of 9 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Lansoprazole nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color Pink / Green
ShapeCapsule
Imprint24HR
Size15 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.407 $17.08 / 42 capsules
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.4438 $18.64 / 42 capsules
NADAC price history (per ea) — tap or hover for the price & month
Nov 2022 Dec 2025 Apr 2026 Sep 2026 $0.467 $0.380
▼ Down 13% over the last 14 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Lansoprazole 15 mg 00093-7350-56 Teva 30 capsules $0.147 AB Availability likely save 64%
Lansoprazole 15 mg 00378-8015-93 Mylan 30 capsules $0.147 AB Availability likely save 64%
Lansoprazole 15 mg 60687-0111-21 American 1 capsule $0.147 AB Availability likely save 64%
Lansoprazole 15 mg 67877-0274-30 Ascend 30 capsules $0.147 AB Availability likely save 64%
Lansoprazole 15 mg 68001-0111-04 BluePoint 30 capsules $0.147 AB Availability likely save 64%
Lansoprazole 15 mg 70756-0806-30 Lifestar 30 capsules $0.147 AB Availability likely save 64%
Good Sense Lansoprazole 15 mg 00113-1114-01 L. 14 capsules $0.407 — Availability likely —
Lansoprazole 15 mg 00536-1368-13 Rugby 14 capsules $0.407 — Availability likely —
lansoprazole 15 mgthis 45802-0878-03 Padagis 14 capsules $0.407 — Availability likely —
good neighbor pharmacy lansoprazole 15 mg 46122-0698-04 Amerisource 14 capsules $0.407 — Availability likely —
Lansoprazole 15 mg 46122-0744-04 AMERISOURCEBERGEN 14 capsules $0.407 — Availability likely —
foster and thrive acid reducer 15 mg 70677-1103-01 Strategic 14 capsules $0.407 — Availability likely —
Lansoprazole 15 mg 83324-0001-14 Chain 14 capsules $0.407 — Availability likely —
Lansoprazole 15 mg 70000-0612-01 LEADER/ 14 capsules $0.432 — Availability likely +6%
Prevacid 24 HR 15 mg 00113-6117-01 L. 14 capsules — — FDA listed —
Lansoprazole 15 mg 00363-0037-14 Walgreens 14 capsules — — FDA listed —
lansoprazole 15 mg 00363-1212-01 Walgreen 14 capsules — — FDA listed —
up and up lansoprazole 15 mg 11673-0280-01 Target 14 capsules — — FDA listed —
Lansoprazole 15 mg 11673-0324-42 Target 14 capsules — — Discontinued —
Lansoprazole 15 mg 11822-0019-01 Rite 14 capsules — — Discontinued —
Lansoprazole 15 mg 11822-3374-05 Rite 14 capsules — — FDA listed —
Lansoprazole 15 mg 21130-0046-14 Albertsons 14 capsules — — Discontinued —
signature care acid reducer 15 mg 21130-0181-01 Safeway 14 capsules — — Discontinued —
Lansoprazole 15 mg 27241-0019-03 Ajanta 30 capsules — — FDA listed —
Lansoprazole 15 mg 30142-0983-14 Kroger 14 capsules — — Discontinued —
Lansoprazole 15 mg 31722-0570-01 Camber 100 capsules — AB FDA listed —
Lansoprazole 15 mg 33342-0310-07 Macleods 30 capsules — — FDA listed —
topcare lansoprazole 15 mg 36800-0392-01 Topco 14 capsules — — FDA listed —
Lansoprazole 15 mg 37808-0934-14 H 14 capsules — — Discontinued —
equaline lansoprazole 15 mg 41163-0150-01 United 14 capsules — — FDA listed —
lansoprazole 15 mg 41250-0391-01 Meijer 14 capsules — — FDA listed —
Lansoprazole 15 mg 43598-0109-27 Dr. 14 capsules — — FDA listed —
Lansoprazole 15 mg 43598-0161-33 Dr. 14 capsules — — FDA listed —
equate lansoprazole delayed release 15 mg 49035-0411-01 Wal-Mart 14 capsules — — FDA listed —
Lansoprazole 15 mg 50090-6079-00 A-S 30 capsules — AB FDA listed —
Lansoprazole 15 mg 51316-0006-14 CVS 14 capsules — — Discontinued —
Lansoprazole 15 mg 55111-0398-01 Dr.Reddy's 100 capsules — AB FDA listed —
Lansoprazole 15 mg 55111-0739-27 Dr. 14 capsules — — FDA listed —
dg health lansoprazole 15 mg 55910-0307-01 Dolgencorp 14 capsules — — FDA listed —
lansoprazole 15 mg 56062-0117-01 Publix 14 capsules — — FDA listed —
lansoprazole 15 mg 56062-0283-01 Publix 14 capsules — — FDA listed —
Kirkland Signature Lansoprazole 15 mg 63981-0582-03 Costco 14 capsules — — FDA listed —
Lansoprazole 15 mg 68071-2274-06 NuCare 60 capsules — AB FDA listed —
Lansoprazole 15 mg 68071-3633-03 NuCare 30 capsules — AB FDA listed —
Lansoprazole 15 mg 68071-3634-03 NuCare 30 capsules — AB FDA listed —
Lansoprazole 15 mg 68071-3687-03 NuCare 30 capsules — AB FDA listed —
Lansoprazole 15 mg 68071-4456-06 NuCare 60 capsules — AB FDA listed —
Lansoprazole 15 mg 68196-0045-03 Sam's 14 capsules — — Discontinued —
Members Mark Lansoprazole 15 mg 68196-0279-03 Sam's 14 capsules — — FDA listed —
Berkley And Jensen Lansoprazole 15 mg 68391-0823-03 BJWC 14 capsules — — FDA listed —
Lansoprazole 15 mg 68788-6390-01 Preferred 100 capsules — AB FDA listed —
Lansoprazole 15 mg 69842-0755-14 CVS 14 capsules — — FDA listed —
Lansoprazole 15 mg 70700-0262-30 Xiromed 30 capsules — AB FDA listed —
Lansoprazole 15 mg 71335-0058-01 Bryant 30 capsules — AB FDA listed —
Lansoprazole 15 mg 71335-2957-01 Bryant 30 capsules — AB FDA listed —
Lansoprazole 15 mg 71335-9680-01 Bryant 30 capsules — AB FDA listed —
Lansoprazole 15 mg 71335-9693-01 Bryant 30 capsules — AB FDA listed —
lansoprazole 15 mg 71335-9695-01 Bryant 30 capsules — — FDA listed —
basic care lansoprazole 15 mg 72288-0301-01 Amazon.com 14 capsules — — FDA listed —
basic care lansoprazole 15 mg 72288-0343-01 Amazon.com 14 capsules — — FDA listed —
careone acid reducer 15 mg 72476-0020-01 Retail 14 capsules — — Discontinued —
equate lansoprazole 15 mg 79903-0068-01 WALMART 14 capsules — — FDA listed —
Lansoprazole DR 15 mg 80425-0148-01 Advanced 30 capsules — AB FDA listed —
Lansoprazole 15 mg 68071-2734-06 NuCare 60 capsules — AB FDA listed —
Lansoprazole 15 mg 72288-0827-03 Amazon.com 14 capsules — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2021
On the market since
Jul 2021
📍
2026
Currently FDA-listed
5 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
14 capsules45802-0878-02 113 Rx · $2,963
14 capsules45802-0878-01 No Medicaid data
14 capsules this page45802-0878-03 No Medicaid data
Drug total (last 4 qtrs): 113 Rx · 3,368 units · $2,963 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Lansoprazole — the program that covers self-administered drugs. 13 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Lansoprazole. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.11M
Claims incl. refills
326.1K
Beneficiaries
241.2K
Spend / beneficiary
$46.07
Spend / claim
$34.08
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Lansoprazole — the ingredient across all brands.

Top reported reactions

Chronic Kidney Disease32,791
Acute Kidney Injury18,792
Renal Failure13,844
End Stage Renal Disease9,798
Renal Injury9,520
Nausea9,253
Diarrhoea9,101

Age at onset

Neonate44
Infant117
Child500
Adolescent444
Adult9,550
Elderly9,907

Reporter sex

177,063 reports
Male · 42%
Female · 58%
Unknown · 0%

Serious outcomes

Hospitalization64,594
Life-threatening12,268
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 25,105 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
45802-0878-01 1 BOTTLE in 1 CARTON (45802-878-01) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE $0.4067 / ea $5.69 2021-07-29 Active
45802-0878-02 2 BOTTLE in 1 CARTON (45802-878-02) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE $0.4067 / ea $11.39 2021-07-29 Active
45802-0878-03 You're viewing this 3 BOTTLE in 1 CARTON (45802-878-03) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE $0.4067 / ea $17.08 2021-07-29 Active

This pack effectively ties for the lowest per-ea cost of the 3 priced pack sizes ($0.4067 NADAC).

This pack shows little to no recent Medicaid volume — a different pack size carries most fills. See all packs ↓

Pack size FAQ

What quantity is in NDC 45802-0878-03?
NDC 45802-0878-03 is listed by the FDA — 3 bottle in 1 carton / 14 capsule, delayed release in 1 bottle.
What NDC number is used to bill for this package of lansoprazole 15 mg Capsule, Delayed Release?
Bill NDC 45802-0878-03 — the 11-digit billing format is 45802087803. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 31 words ▾

Use • treats frequent heartburn (occurs 2 or more days a week) • not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect

⏱️ Dosage and Administration 166 words ▾

Directions • adults 18 years of age and older • this product is to be used once a day (every 24 hours), every day for 14 days • it may take 1 to 4 days for full effect, although some people get complete relief of symptoms within 24 hours 14-Day Course of Treatment • swallow 1 capsule with a glass of water before eating in the morning • take every day for 14 days • do not take more than 1 capsule a day • swallow whole. Do not crush or chew capsules. • do not use for more than 14 days unless directed by your doctor Repeated 14-Day Courses (if needed) • you may repeat a 14-day course every 4 months • do not take for more than 14 days or more often than every 4 months unless directed by a doctor • children under 18 years of age: ask a doctor before use.

Heartburn in children may sometimes be caused by a serious condition.

⚠️ Warnings ~1 min read ▾

Warnings Allergy alert: • do not use if you are allergic to lansoprazole • lansoprazole may cause severe skin reactions. Symptoms may include: • skin reddening • blisters • rash If an allergic reaction occurs, stop use and seek medical help right away. Do not use if you have: • trouble or pain swallowing food, vomiting with blood, or bloody or black stools. • heartburn with lightheadedness, sweating or dizziness • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness • frequent chest pain These may be signs of a serious condition.

See your doctor. Ask a doctor before use if you have • liver disease • had heartburn over 3 months. This may be a sign of a more serious condition. • frequent wheezing, particularly with heartburn • unexplained weight loss • nausea or vomiting • stomach pain Ask a doctor or pharmacist before use if you are • taking a prescription drug.

Acid reducers may interact with certain prescription drugs. Stop use and ask a doctor if • your heartburn continues or worsens • you need to take this product for more than 14 days • you need to take more than 1 course of treatment every 4 months • you get diarrhea • you develop a rash or joint pain If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 43 words ▾

Other information • read the directions and warnings before use • keep the carton. It contains important information. • store at 20-25°C (68-77°F) • keep product out of high heat and humidity • protect product from moisture • close cap tightly after use

🧪 Active Ingredient 8 words ▾

Active ingredient (in each capsule) Lansoprazole 15 mg

🧪 Inactive Ingredients 43 words ▾

Inactive ingredients D&C red no. 28, D&C yellow no. 10, FD&C blue no. 1, FD&C red no. 40, gelatin, hypromellose, low substituted hydroxypropyl cellulose, mannitol, meglumine, methacrylic acid copolymer, pharmaceutical ink, polyethylene glycol, polysorbate 80, sodium lauryl sulfate, sugar spheres, talc, titanium dioxide

🎯 Purpose 3 words ▾

Purpose Acid Reducer

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 45802-0873-05 · Padagis 45802-0880-14 · Padagis →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.